Skip to content

Establishment and application of AD digital medical model based on digital medicine

Establishment and application of AD digital medical model

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100055059
Enrollment
Unknown
Registered
2021-12-31
Start date
2022-04-30
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Interventions

Control group:None
Case group:None

Sponsors

Beijing Chaoyang Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Case group inclusion criteria: (1) Patients aged >50 years; (2) Patients with cognitive impairment indicated by the Mini-Mental State Scale (MMSE) score test; (3) Elderly people with MMSE scores between 0 and 23; (4) Patients with brain CT or MRI, clinical manifestations, and laboratory examinations that suggest no cerebral hemorrhage, cerebral infarction, or intracranial mass. 2. Inclusion criteria for the control group: (1) Aged >50 years, healthy elderly persons whose age and gender are matched with the case group; (2) No central nervous system disease, no serious heart, liver, kidney and other internal diseases and neuropsychiatric diseases; (3) No impairment of cognitive function and activities of daily living, can not be diagnosed as dementia, MMSE > 26 points.

Exclusion criteria

Exclusion criteria: Case group exclusion criteria: 1. Patients with other types of dementia, such as patients with advanced Parkinson's disease, patients with intracranial infection, schizophrenia, and depression; completely independent and mildly dependent, and patients with bleeding and ischemic cerebrovascular disease; 2. Patients with severe heart, liver, lung and renal insufficiency; 3. Patients with obvious failure.

Design outcomes

Primary

MeasureTime frame
Amyloid;Phosphorylated Tau;

Countries

China

Contacts

Public ContactZhang Juan

Beijing Chaoyang Hospital Affiliated to Capital Medical University

ruyidudulily@sina.com+86 13910165831

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026